BCL2 and breast cancer: We performed BCL2 SMPC and PBA profiling on the initial (BC-7064) and relapsed (BC-7064-R) samples using our technique in a retrospective manner, comparing the three diagnostic PPI metrics in the combined model (Fig. 4h).